Clinical Trial Update: Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse [Phase 2]

View source ↗

Summary

Pfizer-sponsored Phase 2 trial evaluating Leflunomide in patients with first-relapse anaplastic astrocytoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: Pfizer | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED